Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Concenter BioPharma Ltd. logo — Developing Novel, First in Class Drug, Targeting Type 2 Diab...

Concenter BioPharma Ltd.

Developing Novel, First in Class Drug, Targeting Type 2 Diabetes, Based on a Core-Technology-Platform

Founded 2013 3 employees Biopharma, Biotechnology +3

General Information

Company Name Concenter BioPharma Ltd.
Founded Year 2013
Employees 3
Industries Biopharma, Biotechnology, Information Technology +2
Social

Get notified when Concenter BioPharma Ltd. moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Concenter BioPharma Ltd.

Concenter BioPharma Ltd. is a biopharmaceutical startup founded in 2013. The company's slogan, "Developing Novel, First in Class Drug, Targeting Type 2 Diabetes, Based on a Core-Technology-Platform," reflects its focus on developing innovative therapies for type 2 diabetes and other life-threatening diseases. Concenter BioPharma has patented a unique, proven, and novel platform of drugs with 3 modes of action, positioning itself at the forefront of the biopharma, biotechnology, information technology, life sciences, and pharmaceutical industries. The company is dedicated to advancing a pipeline of products with vast potential in addressing multi­billion-dollar markets for treating diseases that require common modes of action facilitated by their platform. Their goal is to become a global specialty biopharmaceutical company, prioritizing providing innovative therapies for individuals living with life-threatening diseases. One of the key advantages of Concenter BioPharma's platform is its ability to swiftly transition from one product to another without the need to rediscover and recreate the underlying technology for each new therapy. This capability streamlines their product development process and enhances their agility in bringing new treatments to market efficiently. While the exact headquarters location and details of the last investment, including investors and investment amount, are not provided, Concenter BioPharma's commitment to developing and delivering therapies that work harmoniously with the human body underscores its potential as an investment opportunity in the rapidly evolving biopharmaceutical sector.

Taxonomy: Biopharmaceuticals, Drug Development, Diabetes Treatment, Pharmaceutical Research, Platform Technology, Oral Drug Administration, Innovative Therapies, Life-threatening Diseases, Specialty Biopharmaceuticals

No funding data available for Concenter BioPharma Ltd. yet.

Get notified when Concenter BioPharma Ltd. raises funding

Concenter BioPharma Ltd. Alternatives & Competitors

Concenter BioPharma Ltd. vs
Enterprise Therapeutics
Enterprise Therapeutics United Kingdom

Dedicated to the development of novel therapies to improve the lives of patients with respiratory di...

Series B
13 employees
Health Care, Health and Wellness
Concenter BioPharma Ltd. vs
Seachaid Pharmaceuticals
Seachaid Pharmaceuticals

Bringing advanced therapies to life, enabling patients to recover at home after shorter hospital sta...

2-10 employees
Biotechnology, Health Care
Concenter BioPharma Ltd. vs
Mid-Atlantic BioTherapeutics (MABT)
Mid-Atlantic BioTherapeutics (MABT) United States

MABT: Impacting disease with innovative treatments.

Series Unknown
4 employees
Life Sciences, Pharmaceutical

FAQ About Concenter BioPharma Ltd.

Developing Novel, First in Class Drug, Targeting Type 2 Diabetes, Based on a Core-Technology-Platform
Concenter BioPharma Ltd. was founded in 2013.
Concenter BioPharma Ltd. operates in the following industries: Biopharma, Biotechnology, Information Technology, Life Sciences, Pharmaceutical.
Concenter BioPharma Ltd. has approximately 3 employees.
Top alternatives and competitors to Concenter BioPharma Ltd. include Enterprise Therapeutics, Seachaid Pharmaceuticals, Mid-Atlantic BioTherapeutics (MABT), Caribou Biosciences, Ethris. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Concenter BioPharma Ltd. and Enterprise Therapeutics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Concenter BioPharma Ltd. and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes